A Specific Cervicograph for Women Attempting at Vaginal Delivery After Cesarean Section

September 29, 2017 updated by: Michel Boulvain, University Hospital, Geneva

A Specific Cervicograph for Women Attempting at Vaginal Delivery After Cesarean Section: is the Management of Labor Improved?

The main objective is to evaluate a specific cervicograph (the graph describing the cervical dilation, included in the partograph) for pregnant women with an history of cesarean section, to improve the management of labor for women attempting at a vaginal delivery (VBAC). Women will be randomly assigned to this specific cervicograph (including an action line 2 hours after the alert line), or to the normal cervicograph (no lines). The primary outcome is appropriate detection of dystocia.

Study Overview

Detailed Description

Appropriate management of labor is essential to minimize the risk of uterine rupture in case of attempt at vaginal delivery after a cesarean section (VBAC). Dystocia is a known risk factor for uterine rupture during labor in women with previous cesarean section. Some studies have shown that this risk increases after 2 hours at the same cervical dilation during labor. The cervicograph is an important tool to detect dystocia during labor. There is currently no specific cervicograph for pregnant women with a history of cesarean section, and no study evaluated the cervicograph in the monitoring of labor for women with a scarred uterus.

The main objective is to evaluate a specific cervicograph (the graph describing the cervical dilation, included in the partograph) for pregnant women with an history of cesarean section, to improve the management of labor for women attempting at a vaginal delivery (VBAC). Women will be randomly assigned to a specific cervicograph (including an action line 2 hours after the alert line), or to the normal cervicograph (no lines).

The outcomes of this randomized trial are: appropriate detection and management of dystocia; uterine rupture; and success of VBAC.

Study Type

Interventional

Enrollment (Actual)

135

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women in labor, admitted for a VBAC at a gestational age of 37 weeks or more
  • Single pregnancy
  • Cephalic presentation

Exclusion Criteria:

  • More than 1 previous cesarean section
  • Multiple pregnancies
  • Presentations other than cephalic
  • History of low vertical uterotomy, classical or inverted T-shaped
  • Past history of myomectomy
  • Fetal death
  • Fetal anomalies
  • Placental anomalies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: specific cervicograph
Specific cervicograph, including an alert line (normal progression of cervical dilation, i.e. 1 cm per hour) and an action line 2 hours after the alert line. This should be completed after the diagnose of active labor
Other Names:
  • usual cervicograph
No Intervention: Usual cervicograph
The usual cervicograph in our unit is not having lines

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detection of dystocia during labor in women with past history of cesarean section
Time Frame: From inclusion in the study (randomization usually from 2cm) until full cervical dilation.
Appropriate detection and management of dystocia by identifying women with: no progression of cervical dilation for more than 2 hours during labor; or slow progress, defined as a cervical dilation of less than 2 cm in 4 hours; and immediate decision of cesarean section, to be performed within 30 minutes.
From inclusion in the study (randomization usually from 2cm) until full cervical dilation.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Uterine rupture during labor in women with past history of cesarean section
Time Frame: From inclusion in the study (randomization usually from 2cm) until delivery
Uterine rupture will be defined as a complete separation of the uterine scar that resulted in protrusion of fetal or placental parts in the peritoneal cavity
From inclusion in the study (randomization usually from 2cm) until delivery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of VBAC
Time Frame: at delivery
Percentage of vaginal delivery in women with past history of cesarean section
at delivery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 26, 2013

Primary Completion (Actual)

October 11, 2016

Study Completion (Actual)

October 11, 2016

Study Registration Dates

First Submitted

September 26, 2017

First Submitted That Met QC Criteria

September 29, 2017

First Posted (Actual)

October 2, 2017

Study Record Updates

Last Update Posted (Actual)

October 2, 2017

Last Update Submitted That Met QC Criteria

September 29, 2017

Last Verified

September 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 12-173 MATPED 12-036

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attempted Vaginal Delivery After a Cesarean Section

Clinical Trials on specific cervicograph

3
Subscribe